Volver a Agenda
LS20 Open Innovation in Drug Development in Japan: Preparations in Normal Times, Challenges, and Practices
Session Chair(s)
Makoto Nagaoka, PHD
Senior Director, Global Regulatory Affairs Strategy, Consulting
Fortrea Japan K.K., Japan
Speaker(s)
Kotone Matsuyama, RPH
National Center for Child Health and Development, Japan
Center for Clinical Research and Development
Keiichi Fukuda, MD, PHD
Graduate School of Medicine, Keio University, Japan
Professor, Department of Regenerative Medicine and Advanced Cardiac Therapeutics
Noriatsu Kono, MPHARM
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Organizational management
Liu Lei
AstraZeneca K.K., Japan
Innovation Partnerships & i2.JP Director
¿Tiene una cuenta?